'Mixed effects models' diaporamas de présentation

Raymond J. Carroll Department of Statistics Member, Center for Statistical Bioinformatics

The Interface of Functional and Longitudinal Data. Raymond J. Carroll Department of Statistics Member, Center for Statistical Bioinformatics Director, Institute for Applied Mathematics and Computational Science Texas A&M University http://stat.tamu.edu/~carroll. My Charge.

924 views • 74 slides

HRP 223 - 2008

723 views • 58 slides

MULTILEVEL ANALYSIS

MULTILEVEL ANALYSIS. Kate Pickett Senior Lecturer in Epidemiology. SUMBER: www-users.york.ac.uk/.../Multilevel%20 Analysis . ppt ?University of York. Perspective. Health researchers: Are interested in answering research questions (not maths) Want to be able to apply statistical techniques

962 views • 42 slides

Factorial Models

Factorial Models. Random Effects Gauge R&R studies (Repeatability and Reproducibility) have been an expanding area of application Mixed Effects Models. One-way Random Effects. The one-way random effects model is quite different from the one-way fixed effects model

767 views • 36 slides

PK/PD Modeling in Support of Drug Development

PK/PD Modeling in Support of Drug Development. Alan Hartford, Ph.D. Associate Director Scientific Staff Clinical Pharmacology Statistics Merck Research Laboratories, Inc. alan_hartford@merck.com. Outline. Introduction Purpose of PK/PD modeling The Model Modeling Procedure

702 views • 30 slides

649 views • 28 slides

298 views • 28 slides

Impact of Exploratory Analysis on Drug Approval

Impact of Exploratory Analysis on Drug Approval. Joga Gobburu Pharmacometrics Office Clinical Pharmacology, CDER, FDA. jogarao.gobburu@fda.hhs.gov. Take Home Message. Exploratory (e.g., pharmacometric) analyses are often used to make regulatory decisions

381 views • 24 slides